UBS AM’s Immuneering IMRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$708 Buy
+173
New +$817 ﹤0.01% 4159

Other funds holding IMRX

UBS AM's IMRX Position: Q3 2026 in Review

UBS AM opened a new position in Immuneering (IMRX) in Q3 2026: 173 shares worth $708. The stake represents ﹤0.01% of the portfolio and ranks #4159 among its holdings.

112 funds tracked by Wall St. Rank hold IMRX as of Q3 2026.

  • UBS AM held 173 shares of Immuneering worth $708 as of Q3 2026.
  • Immuneering was a new UBS AM position in Q3 2026.
  • Immuneering made up ﹤0.01% of UBS AM's portfolio in Q3 2026, its #4159 holding.
  • 112 funds tracked by Wall St. Rank held Immuneering as of Q3 2026.

Based on UBS AM's 13F filing for Q3 2026, filed 16 Nov 2026.